Hypertension and left ventricular geometry: Diagnosis, prognosis, and management

Samantha M Mutai1, Namrata Kadambi1, Mattin Moazzam1

  • 1Department of Medicine, Division of Cardiology, Rush University Medical Center, Chicago, IL, United States.

EXCLI Journal
|June 30, 2026
PubMed

Insights

Hypertension significantly impacts heart health, altering left ventricular (LV) geometry and potentially leading to heart failure. Early detection and reversal of hypertensive LV remodeling are crucial for preventing cardiovascular disease progression.

Area of Science:

  • Cardiology
  • Cardiovascular Research
  • Hypertension Research

Background:

  • Hypertension is a major global cardiovascular risk factor, frequently leading to heart disease.
  • Hypertensive heart disease involves changes in left ventricular (LV) geometry, such as remodeling and hypertrophy, which can progress to heart failure.
  • LV geometric patterns are critical diagnostic and prognostic indicators, independent of blood pressure levels.

Purpose of the Study:

  • To provide a comprehensive review of the relationship between hypertension and LV geometry.
  • To summarize determinants of hypertensive LV remodeling and discuss diagnostic/prognostic implications.
  • To explore strategies for the early identification and reversal of LV remodeling to prevent heart failure.

Main Methods:

  • Review of current literature on hypertension and LV geometry.
  • Analysis of determinants including blood pressure, sex, comorbidities, obesity, and sleep apnea.
  • Evaluation of diagnostic tools like ECG, echocardiography, and cardiac MRI, including AI applications.

Main Results:

  • LV geometric patterns are key in hypertensive heart disease, influencing prognosis.
  • Factors like cumulative BP, sex, obesity, and sleep apnea significantly affect LV remodeling.
  • Emerging AI tools show promise in improving LV assessment and prognostication.

Conclusions:

  • Hypertensive LV remodeling is a critical factor in cardiovascular morbidity and mortality.
  • Early identification and intervention, including BP control and lifestyle changes, can reverse LV hypertrophy.
  • Reversing LV remodeling offers a vital opportunity to prevent heart failure and improve long-term outcomes.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...